IP Library Granted Patent US 8,968,997
Granted Patent B2
US 8,968,997 · App. 13/965,566 · Granted Mar 3, 2015

Benzoxazole-based fluorescent metal ion indicators

Inventors: Kyle Gee (Springfield, OR); Vladimir Martin (Eugene, OR)
Assignee: Life Technologies Corporation
G01N21/75C07D263/56C07D263/57C07D401/04C07D413/04C07D417/04C07D471/06C07D491/16C09K11/06G01N33/582G01N33/84C09K2211/1007C09K2211/1014C09K2211/1029C09K2211/1033C09K2211/1037C09K2211/1048C09K2211/1088
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,968,997
App. No.
13/965,566
Granted
Mar 3, 2015
Kind
B2
Abstract

Disclosed are benzoxazole-based compounds, kits, and methods of producing and using the described compounds in fluorescence-based detection of analytes (e.g., metal ions). Also disclosed are uses of benzoxazole-based compounds as ratiometric metal ion indicators.

Claims (48)

1. A method of measuring the concentration of metal ions in a sample, comprising:

a) combining a fluorescent compound comprising a 2-substituted benzoxazole group attached to a metal ion binding group with a sample known or suspected to contain a metal ion in an amount sufficient to generate a detectable fluorescent response to the metal ion;

b) illuminating the sample to generate a fluorescence excitation or emission response;

c) observing the absorbance or emission response; and

d) quantifying the fluorescence excitation or emission response of the compound to determine the concentration of metal ions in the sample.

2. The method of claim 1 , wherein the compound generates a fluorescence excitation or emission response in the visible region of the electromagnetic spectrum.

3. The method of claim 1 , wherein the compound exhibits a change in emission wavelength maximum upon binding to the metal ion.

4. The method of claim 1 , wherein the compound exhibits a change in excitation wavelength maximum upon binding to the metal ion.

5. The method of claim 3 or 4 , wherein the excitation or emission wavelength maximum shifts about 20 nm or greater upon metal ion binding.

6. The method of claim 1 , wherein the compound comprises a BAPTA crown ether or cryptand group.

7. The method of claim 1 , wherein the metal ion is monovalent.

8. The method of claim 7 , wherein the monovalent metal ion is selected from the group consisting of Na + , Li + , K + , Tl + , trialkylammonium and tetraalkylammonium.

9. The method of claim 1 , wherein the metal ion is divalent.

10. The method of claim 9 , wherein the divalent metal ion is selected from the group consisting of Ca 2+ , Zn 2+ , Mg 2+, Pb 2+ , Hg 2+ and Pb 2+ .

11. The method of clam 1 , wherein the fluorescent compound is water-soluble.

12. The method of claim 1 , wherein the sample is an aqueous solution.

13. The method of claim 1 , wherein the sample comprises living cells or biological fluids.

14. The method of claim 1 , wherein the fluorescent compound is permeant to membranes of biological cells.

15. The method of claim 1 , wherein the compound has the formula:

or a salt thereof,

wherein M is —NCH 2 -Py or —N(CH 2 COOR 5 ) 2 , wherein R 5 is H, an alkyl having 1-6 carbons, —CH 2 OCOCH 3 , or a counterion;

Y is —CH 3 , —CH 2 COOH, —CH 2 COOPy, or

X is —N(CH 2 COOR 5 ) 2 , —NCH 2 Py, —OCH 2 Py, or —OCH 2 COOR 5 ;

R 7 , R 8 , R 9 , and R 10 are independently selected from the group consisting of an alkyl having 1-6 carbons, halogen, amino, nitro, cyano, trifluoromethyl, sulfo, and sulfonamide;

R 1 and R 2 are independently H, an alkyl having 1-6 carbons, halogen, or sulfo;

R 4 is a 5 or 6-membered aromatic ring or a fused ring system comprising at least one 6-membered aromatic ring;

L is an alkylene having 2-6 carbons; and

p is 0 or 1.

16. The method of claim 1 , wherein the compound has the formula:

or a salt thereof,

wherein M is —NR 3 —, wherein R 3 is —CH 2 -Py, —CH 2 Py, —CH 2 CH 2 OR 5 , or —CH 2 COOR 5 , wherein R 5 is H, an alkyl having 1-6 carbons, —CH 2 OCOCH 3 , or a counterion;

Z is

 or

 wherein n is 1, 2, or 3;

R 6 is —CH 2 COOR 5 , —CH 2 CH 2 OR 5 , —CH 2 Py, or, when taken in combination with M, forms a structure

 wherein m is 1, 2, or 3;

R 7 , R 8 , R 9 , and R 10 are independently selected from the group consisting of an alkyl having 1-6 carbons, halogen, amino, nitro, cyano, trifluoromethyl, sulfo, and sulfonamide;

R 1 and R 2 are independently H, an alkyl having 1-6 carbons, halogen, or sulfo;

R 4 is a 5 or 6-membered aromatic ring or a fused ring system comprising at least one 6-membered aromatic ring;

L is an alkylene having 2-6 carbons; and

p is 0 or 1.

17. A method of measuring the concentration of intracellular metal ions in a sample, comprising:

a) combining a fluorescent compound comprising a 2-substituted benzoxazole group attached to a metal ion binding group with a sample containing biological cells, wherein the cells are known or suspected to contain metal ions, in an amount sufficient to generate a detectable fluorescent response to a metal ion;

b) illuminating the sample to generate a fluorescence excitation or emission response;

c) observing the absorbance or emission response; and

d) quantifying the fluorescence excitation or emission response of the compound to determine the concentration of the metal ions within the cells.

18. The method of claim 17 , wherein the biological cells are living cells.

19. The method of claim 17 , wherein the fluorescent compound is permeant to membranes of the biological cells.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2013
From: GEE, KYLE; MARTIN, VLADIMIR
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 031184/0026 →
Continuity (3)
Division 13142584
Provisional Application 61141181 · Dec 29, 2008
Related Publication 20140045171A1 · Feb 13, 2014